These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1143215)

  • 21. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage].
    Mattone PG; Meriggi E; De Martin G
    Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573
    [No Abstract]   [Full Text] [Related]  

  • 22. [Histological peculiarities of the placenta in materno-fetal isoimmunization due to Rh factors].
    Capone N; Urbanetti S; Sobrino R; Sobrino S
    Minerva Ginecol; 1982 Mar; 34(3):151-4. PubMed ID: 6806722
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anti-D isoimmunization: cases at the L. Mangiagalli Obstetrical and Gynecological Clinic I from June 1974 to December 1978. Perinatal results].
    Brambati B; Zuliani G; Regalia AL; Pardi G; Chierichetti G; Dambrosio F; Caccamo ML
    Ann Ostet Ginecol Med Perinat; 1980; 101(4):225-34. PubMed ID: 6787970
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serologic incompatibility and family planning].
    Matýsek P; Ungerová A; Cuprová M; Muchová M
    Cesk Gynekol; 1988 Aug; 53(7):497-9. PubMed ID: 3168017
    [No Abstract]   [Full Text] [Related]  

  • 25. [Maternal anti-Rh isoimmunization and fetal erythroblastosis in the Clinica Ostetrica e Ginecologica of the University of Perugia in the 15-year-period 1962-66].
    Di Stefano M
    Arch Ostet Ginecol; 1967; 72(6):780-802. PubMed ID: 4974764
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prospects of the clinical use of immunosuppressive agents in control of materno-fetal Rh isoimmunization and in attempted prevention. (Theoretical presuppositions and preliminary clinical experiences)].
    Vecchietti G; Onnis A
    Minerva Ginecol; 1970 May; 22(9):459-62. PubMed ID: 4995415
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunologic and pathogenic problems posed by hemolytic diseases caused by Rhesus incompatibility of the firstborn infant].
    Gabriel H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):231-2. PubMed ID: 4220063
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemolytic disease of the newborn caused by Rh isoimmunization in first-born children].
    Lange MM; Corsino G; Perfetto V
    Minerva Pediatr; 1968 Mar; 20(11):623-4. PubMed ID: 4983211
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hemolytic disease of the newborn in first-born infants. (Clinical contribution)].
    Baratta A; Torsiglieri W
    Quad Clin Ostet Ginecol; 1966 Sep; 21(9):587-94. PubMed ID: 5993026
    [No Abstract]   [Full Text] [Related]  

  • 31. [Transmissions of fetal blood to the mother as the cause of leukoalloimmunization in pregnancy].
    Spensieri S; Carnevale-Arella E; De Geronimi G
    Minerva Ginecol; 1970 May; 22(10):500-18. PubMed ID: 5515282
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention and treatment of Rh. isoimmunization. Results].
    Martínez M; Lozano G; Flores F; Fernández P; Garrido G
    Acta Obstet Ginecol Hisp Lusit; 1971 Mar; 19(2):149-57. PubMed ID: 4996734
    [No Abstract]   [Full Text] [Related]  

  • 33. [2 cases of anti-Kell antibody detection].
    Bashlaĭ AG; Kissel'gof AM
    Probl Gematol Pereliv Krovi; 1966 May; 11(5):58-60. PubMed ID: 5993247
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of hemolytic disease of the newborn caused by maternal anti-Fyl alloimmunization].
    Agosti S; Moroni GA; Zuliani G; Meschia M
    Ann Ostet Ginecol Med Perinat; 1980; 101(1):55-9. PubMed ID: 7396333
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hemolytic disease of the newborn infant caused by the Kidd-system blood incompatibility].
    Dzierzkowa-Borodej W; Maszkiewicz W; Wiewiórowska E
    Pediatr Pol; 1977 Feb; 52(2):215-6. PubMed ID: 557194
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current trends in immunoprophylaxis of anti-Rho isoimmunization].
    Sirchia G; Mercuriali F
    Clin Ter; 1970 Feb; 52(4):385-90. PubMed ID: 5005934
    [No Abstract]   [Full Text] [Related]  

  • 37. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 38. Irregular antibodies in pregnant women.
    Smith BD; Haber JM; Queenan JT
    Obstet Gynecol; 1967 Jan; 29(1):118-24. PubMed ID: 4959779
    [No Abstract]   [Full Text] [Related]  

  • 39. Current concepts in hemolytic disease and blood group incompatibility.
    Cherry SH
    Mt Sinai J Med; 1980; 47(5):454-60. PubMed ID: 6969353
    [No Abstract]   [Full Text] [Related]  

  • 40. Erythroblastosis fetalis secondary to Kell immunization.
    Braun RD
    Tex Med; 1972 May; 68(5):104-6. PubMed ID: 5063530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.